Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03252483 · ClinicalTrials.gov registry record · NA
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department
A NA study of HIV and Hepatitis C, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- NA
- Development phase
- 478
- Enrollment target
- 1
- Study location
NCT03252483 is a NA study of HIV and Hepatitis C that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 478 participants, roughly in line with the 438-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT03252483, a NA study of HIV and Hepatitis C, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 478 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial was implemented to evaluate the effect of integrating rapid Hepatitis C (HCV) testing into a pre-existing screening program for Human Immunodeficiency Virus (HIV) on HIV test acceptance and diagnosis of both HCV and HIV. A sample of 478 adults in a New York City Emergency Department participated in the study. Participants were randomized to receive either an offer of bundled HIV/HCV testing or HIV testing alone. Public Health Advocates approached eligible patients in the Emergency Department, performed HIV and HCV raid testing, and delivered test results to participants with post-test counseling. The primary outcome, HIV test acceptance, was compared between the two groups to evaluate whether the addition of an HCV test adversely impacted participants' consent to test for HIV. Questionnaires were also distributed to participants to assess HCV knowledge.
Conditions Studied
Interventions
- OTHER Bundled HCV/HIV Screening
- OTHER HIV Screening
Study Locations (1)
New York
- Jacobi Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 478 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03252483
The ClinicalTrials.gov registry entry for NCT03252483 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 478 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 438-participant average among 303 other HIV trials with a reported enrollment target. The listed sponsor is New York City Health and Hospitals Corporation, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Bundled HCV/HIV Screening is the first listed.
NCT03252483 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03252483 about?
NCT03252483 is a clinical study titled "Integrating HIV and Hepatitis C Screening in an Urban Emergency Department". This randomized controlled trial was implemented to evaluate the effect of integrating rapid Hepatitis C (HCV) testing into a pre-existing screening program for Human Immunodeficiency Virus (HIV) on HIV test acceptance and diagnosis of both HCV and HIV. A sample of 478 adults in a New York City Emer...
What is the current status of trial NCT03252483?
This trial is currently completed. It is a NA study. The enrollment target is 478 participants. The study started on 2012-12. Estimated completion is 2013-05.
What conditions does trial NCT03252483 study?
This clinical trial studies the following conditions: HIV, Hepatitis C, HIV/AIDS, HIV/AIDS and Infections, HCV Coinfection.
What interventions are being tested in trial NCT03252483?
The interventions under investigation include: Bundled HCV/HIV Screening (OTHER), HIV Screening (OTHER).
Who is sponsoring clinical trial NCT03252483?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03252483 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.